Nuvectis Pharma (NASDAQ:NVCT) lost ~45% on Thursday after the oncology-focused biotech announced data from an ongoing ...

Citigroupa expanded its biotech coverage on Wednesday, adding five more stocks to the roster including Amgen (NASDAQ:AMGN), ...

Bluebird reports 17 people with sickle cell disease started receiving Lyfgenia gene therapy, with 35 starting Zynteglo for ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Sensei Biotherapeutics is laying off 46% of its workforce as the cancer-focused biotech looks to preserve cash to take its ...

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome when the company reports data from a late-stage trial of its treatment for ...

The Biotechnology Innovation Organization (BIO) has commended a recent update from the USDA's Animal and Plant Health Inspection Service (APHIS), which has expanded exemptions for genetically modified ...

Donald Trump's announcement that Elon Musk and Vivek Ramaswamy will lead a newly formed Department of Government Efficiency ...

Suozzi’s unreported financial interest in a promising healthcare startup highlights blurred lines between politics and profit ...

With the new operations site and logistics center in Sydney, “Australian researchers and biotech companies will no longer ...

Thermo Fisher Scientific has strong growth prospects due to easing COVID-19 headwinds, improving Chinese and biotech markets, ...

The clock is ticking for Kronos Bio after the biotech discontinued its last remaining clinical-stage asset over neurological ...